Abstract
IMMUNOLOGICAL enhancement is historically the oldest method for impeding graft rejection. Such an outcome resulting from the injection of antiserum directed against a transplant seemed paradoxical, and the mechanism has been under discussion all through the years of study of antigens as putative tolerogens to the present time when immunological enhancement is the best available method for donor-specific immunosuppression in animal models1. The shortcomings of non-specific immunosuppression at present used in clinical transplantation are so great that an interpretation of the mechanism of immunological enhancement is important, in order to find how the method can best be adapted for clinical use.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
